Ulf Nehrbass

Vorstandsvorsitzender bei Luxembourg Institute of Health

Health Technology

Commercial Services

Profil

Ulf Nehrbass is currently the Chief Executive Officer at Luxembourg Institute of Health.
Previously, he held the same position at Qurient Co., Ltd.

Aktive Positionen von Ulf Nehrbass

Unternehmen	Position	Beginn
Luxembourg Institute of Health Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass.	Vorstandsvorsitzender	-

Alle aktiven Positionen von Ulf Nehrbass

Ehemalige bekannte Positionen von Ulf Nehrbass

Unternehmen	Position	Ende
QURIENT CO., LTD.	Vorstandsvorsitzender	-

Sehen Sie sich die Erfahrung von Ulf Nehrbass im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ulf Nehrbass im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
QURIENT CO., LTD.	Health Technology

Private Unternehmen	1
Luxembourg Institute of Health Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass.	Commercial Services